Trismus management in head and neck cancer survivors: comprehensive rehabilitation-focused review

Standardised rehabilitation protocols, integration of telehealth approaches for adherence support, expansion of evidence in resource-limited settings and investigation of anti-fibrotic pharmacological agents warrant priority in future research. Recognition of trismus as a modifiable survivorship toxicity with rehabilitation-driven solutions is essential for optimising long-term outcomes in HNC survivors.